A Multicenter, International, Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® PmVSD Occluder in Patients With Perimembranous Ventricular Septal Defects

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

July 7, 2019

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2026

Conditions

Perimembranous Ventricular Septal Defect

Trial Locations (5)

Ludwig Maximilians University, Munich

Children Health Ireland, Dublin

Queen Sirikit National Institute of Child Health, Bangkok

Prince of Songkla University, Hat Yai

City Children Hospital, Ho Chi Minh City